Tucker Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$86.1K Buy
417
+142
+52% +$28.4K 0.03% 220
2025
Q3
$49.3K Sell
275
-14
-5% -$2.38K 0.01% 181
2025
Q2
$46.6K Buy
289
+213
+280% +$33.9K 0.01% 167
2025
Q1
$12.9K Buy
76
+34
+81% +$5.91K ﹤0.01% 220
2024
Q4
$6.98K Buy
+42
New +$7.18K ﹤0.01% 884
2021
Q3
Sell
-3
Closed -$518 385
2021
Q2
$518 Sell
3
-2
-40% -$330 ﹤0.01% 338
2021
Q1
$803 Hold
5
﹤0.01% 316
2020
Q4
$840 Buy
+5
New +$811 ﹤0.01% 342

Other funds holding FBT

Tucker Asset Management's FBT Position: Q4 2025 in Review

Tucker Asset Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 52% in Q4 2025, buying an estimated $28.4K and bringing the position to 417 shares worth $86.1K. The position accounts for 0.03% of the portfolio, ranked #220.

Tucker Asset Management first reported a position in FBT in Q4 2020 and has held it in 8 quarters since. 279 funds tracked by Wall St. Rank hold FBT as of Q4 2025.

  • Tucker Asset Management held 417 shares of First Trust NYSE Arca Biotechnology Index Fund worth $86.1K as of Q4 2025.
  • Tucker Asset Management bought 142 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2025, an estimated $28.4K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Tucker Asset Management's portfolio in Q4 2025, its #220 holding.
  • Tucker Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2020 and has held it in 8 quarters since.
  • 279 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.